Kiora Pharmaceuticals Reports KIO-300 Suppresses Seizure Activity in Preclinical Epilepsy Model

Kiora Pharmaceuticals announced that KIO-300, an ion channel modulator, significantly reduced seizure-associated electrophysiological activity in an e...